Works matching IS 13419625 AND DT 2021 AND VI 26 AND IP 5

Results: 24
    1
    2

    Correction to: A multicenter propensity score analysis of FOLFIRINOX vs gemcitabine plus nab-paclitaxel administered to patients with metastatic pancreatic cancer: results from the NAPOLEON study.

    Published in:
    2021
    By:
    • Otsuka, Taiga;
    • Shirakawa, Tsuyoshi;
    • Shimokawa, Mototsugu;
    • Koga, Futa;
    • Kawaguchi, Yasunori;
    • Ueda, Yujiro;
    • Nakazawa, Junichi;
    • Komori, Azusa;
    • Otsu, Satoshi;
    • Arima, Shiho;
    • Fukahori, Masaru;
    • Okabe, Yoshinobu;
    • Makiyama, Akitaka;
    • Taguchi, Hiroki;
    • Honda, Takuya;
    • Shibuki, Taro;
    • Nio, Kenta;
    • Ide, Yasushi;
    • Mizuta, Toshihiko;
    • Mitsugi, Kenji
    Publication type:
    Correction Notice
    3
    4

    Correction to: Effectiveness and safety of nivolumab in patients with head and neck cancer in Japanese real‑world clinical practice: a multicentre retrospective clinical study.

    Published in:
    2021
    By:
    • Hanai, Nobuhiro;
    • Shimizu, Yasushi;
    • Kariya, Shin;
    • Yasumatsu, Ryuji;
    • Yokota, Tomoya;
    • Fujii, Takashi;
    • Tsukahara, Kiyoaki;
    • Yoshida, Masafumi;
    • Hanyu, Kenji;
    • Ueda, Tsutomu;
    • Hirakawa, Hitoshi;
    • Takahashi, Shunji;
    • Ono, Takeharu;
    • Sano, Daisuke;
    • Yamauchi, Moriyasu;
    • Watanabe, Akihito;
    • Omori, Koichi;
    • Yamazaki, Tomoko;
    • Monden, Nobuya;
    • Kudo, Naomi
    Publication type:
    Correction Notice
    5

    Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon EGFR mutations.

    Published in:
    International Journal of Clinical Oncology, 2021, v. 26, n. 5, p. 841, doi. 10.1007/s10147-021-01869-0
    By:
    • Chang, Gee-Chen;
    • Lam, David Chi-Leung;
    • Tsai, Chun-Ming;
    • Chen, Yuh-Min;
    • Shih, Jin-Yuan;
    • Aggarwal, Shyam;
    • Wang, Shuhang;
    • Kim, Sang-We;
    • Kim, Young-Chul;
    • Wahid, Ibrahim;
    • Li, Rubi;
    • Lim, Darren Wan-Teck;
    • Sriuranpong, Virote;
    • Chan, Raymond Tsz-Tong;
    • Lorence, Robert M.;
    • Carriere, Philippe;
    • Raabe, Christina;
    • Cseh, Agnieszka;
    • Park, Keunchil
    Publication type:
    Article
    6
    7
    8

    A multicenter phase II trial of preoperative chemoradiotherapy with S-1 plus oxaliplatin and bevacizumab for locally advanced rectal cancer.

    Published in:
    International Journal of Clinical Oncology, 2021, v. 26, n. 5, p. 875, doi. 10.1007/s10147-021-01868-1
    By:
    • Higashijima, Jun;
    • Tokunaga, Takuya;
    • Yoshimoto, Toshiaki;
    • Eto, Shohei;
    • Kashihara, Hideya;
    • Takasu, Chie;
    • Nishi, Masaaki;
    • Yoshikawa, Kozo;
    • Okitsu, Hiroshi;
    • Ishikawa, Masashi;
    • Miyake, Hidenori;
    • Yagi, Toshiyuki;
    • Kono, Toru;
    • Shimada, Mitsuo
    Publication type:
    Article
    9
    10
    11

    The impact of sex and age on distribution of metastases in patients with renal cell carcinoma.

    Published in:
    International Journal of Clinical Oncology, 2021, v. 26, n. 5, p. 962, doi. 10.1007/s10147-021-01874-3
    By:
    • Rosiello, Giuseppe;
    • Pecoraro, Angela;
    • Deuker, Marina;
    • Stolzenbach, Lara Franziska;
    • Martin, Thomas;
    • Tian, Zhe;
    • Larcher, Alessandro;
    • Capitanio, Umberto;
    • Montorsi, Francesco;
    • Shariat, Shahrokh F.;
    • Kapoor, Anil;
    • Saad, Fred;
    • Briganti, Alberto;
    • Karakiewicz, Pierre I.
    Publication type:
    Article
    12
    13
    14

    The prognostic impact of immune-related adverse events in metastatic renal cell carcinoma patients treated with nivolumab: a real-world multi-institutional retrospective study.

    Published in:
    International Journal of Clinical Oncology, 2021, v. 26, n. 5, p. 954, doi. 10.1007/s10147-021-01872-5
    By:
    • Kato, Taigo;
    • Nagahara, Akira;
    • Kawamura, Norihiko;
    • Nakata, Wataru;
    • Soda, Tetsuji;
    • Matsuzaki, Kyosuke;
    • Hatano, Koji;
    • Kawashima, Atsunari;
    • Ujike, Takeshi;
    • Imamura, Ryoichi;
    • Nishimura, Kensaku;
    • Takada, Shingo;
    • Tsujihata, Masao;
    • Yamaguchi, Seiji;
    • Takao, Tetsuya;
    • Nishimura, Kazuo;
    • Nonomura, Norio;
    • Uemura, Motohide
    Publication type:
    Article
    15

    Survey of the clinical practice pattern of using sentinel lymph node biopsy in patients with gynecological cancers in Japan: the Japan Society of Gynecologic Oncology study.

    Published in:
    International Journal of Clinical Oncology, 2021, v. 26, n. 5, p. 971, doi. 10.1007/s10147-021-01862-7
    By:
    • Togami, Shinichi;
    • Kobayashi, Hiroaki;
    • Niikura, Hitoshi;
    • Shimada, Muneaki;
    • Susumu, Nobuyuki;
    • Tanaka, Tomohito;
    • Terai, Yoshito;
    • Nagai, Tomoyuki;
    • Baba, Tsukasa;
    • Yahata, Hideaki;
    • Yamagami, Wataru;
    • Yamaguchi, Ken;
    • Yamashita, Tsuyoshi;
    • Yaegashi, Nobuo;
    • Katabuchi, Hidetaka;
    • Aoki, Daisuke
    Publication type:
    Article
    16

    Improved oncologic outcomes with increase of laparoscopic surgery in modified complete mesocolic excision with D3 lymph node dissection for T3/4a colon cancer: results of 1191 consecutive patients during a 10-year period: a retrospective cohort study.

    Published in:
    International Journal of Clinical Oncology, 2021, v. 26, n. 5, p. 893, doi. 10.1007/s10147-021-01870-7
    By:
    • Tominaga, Tetsuro;
    • Yamaguchi, Tomohiro;
    • Nagasaki, Toshiya;
    • Akiyoshi, Takashi;
    • Nagayama, Satoshi;
    • Fukunaga, Yosuke;
    • Ueno, Masashi;
    • Konishi, Tsuyoshi
    Publication type:
    Article
    17

    Modified albumin–bilirubin grade to predict eligibility for second-line therapies at progression on sorafenib therapy in hepatocellular carcinoma patients.

    Published in:
    International Journal of Clinical Oncology, 2021, v. 26, n. 5, p. 922, doi. 10.1007/s10147-020-01835-2
    By:
    • Tokunaga, Takayuki;
    • Tanaka, Motohiko;
    • Tanaka, Kentaro;
    • Narahara, Satoshi;
    • Kawasaki, Takeshi;
    • Yoshimaru, Yoko;
    • Nagaoka, Katsuya;
    • Watanabe, Takehisa;
    • Tateyama, Masakuni;
    • Naoe, Hideaki;
    • Sasaki, Yutaka;
    • Tanaka, Yasuhito
    Publication type:
    Article
    18

    A multicenter propensity score analysis of FOLFIRINOX vs gemcitabine plus nab-paclitaxel administered to patients with metastatic pancreatic cancer: results from the NAPOLEON study.

    Published in:
    International Journal of Clinical Oncology, 2021, v. 26, n. 5, p. 941, doi. 10.1007/s10147-021-01859-2
    By:
    • Otsuka, Taiga;
    • Shirakawa, Tsuyoshi;
    • Shimokawa, Mototsugu;
    • Koga, Futa;
    • Kawaguchi, Yasunori;
    • Ueda, Yujiro;
    • Nakazawa, Junichi;
    • Komori, Azusa;
    • Otsu, Satoshi;
    • Arima, Shiho;
    • Fukahori, Masaru;
    • Okabe, Yoshinobu;
    • Makiyama, Akitaka;
    • Taguchi, Hiroki;
    • Honda, Takuya;
    • Shibuki, Taro;
    • Nio, Kenta;
    • Ide, Yasushi;
    • Mizuta, Toshihiko;
    • Mitsugi, Kenji
    Publication type:
    Article
    19

    Preoperative predictors of dysphagia after transoral surgery.

    Published in:
    International Journal of Clinical Oncology, 2021, v. 26, n. 5, p. 835, doi. 10.1007/s10147-021-01860-9
    By:
    • Fujiwara, Kazunori;
    • Taira, Kenkichiro;
    • Donishi, Ryohei;
    • Koyama, Satoshi;
    • Morisaki, Tsuyoshi;
    • Fukuhara, Takahiro;
    • Takeuchi, Hiromi
    Publication type:
    Article
    20
    21
    22
    23
    24